RESEARCH TRIANGLE PARK, N.C. - Tuesday, July 1st 2014 [ME NewsWire]

(BUSINESS WIRE) Quintiles Transnational Holdings Inc. (NYSE: Q) will release its financial results for the second quarter of 2014 prior to its quarterly earnings call on Thursday, July 31, 2014, at 8:00 a.m. EDT.

The conference call will be accessible, live via webcast, on the Investor Relations section of the Quintiles website at www.quintiles.com/investors. To participate via telephone, please dial +1 (855) 484-7367 in the United States or +1 (631) 259-7541 outside the United States, approximately 15 minutes before the scheduled start of the call.

An archived edition of the conference call will be available online at www.quintiles.com/investors after 1:00 p.m. EDT on Thursday, July 31st.

About Quintiles

Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more ... Read more »

INGELHEIM, Germany. - Monday, June 30th 2014 [ME NewsWire]

    Idarucizumab rapidly reverses anticoagulation induced with Pradaxa® and may broaden existing range of reversal options available to physicians in emergency situations1,2
    
    Previous results from study in healthy volunteers show antidote to be well-tolerated with immediate, complete and sustained effect1

(BUSINESS WIRE) For media outside of the U.S., the UK & Canada only

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to the investigational antidote idarucizumab* (a humanized antibody fragment), currently being studied as a specific antidote for the oral anticoagulant Pradaxa® (dabigatran etexilate).3

“In light of Boehringer Ingelheim’s core mission to provide value through innovation, we are pleased that the FDA has granted Breakthrough Therapy Designation to idar ... Read more »

ZUG, Switzerland - Monday, June 30th 2014 [ME NewsWire]

(BUSINESS WIRE)-- Pala Investments is pleased to announce that Michael Barton will assume the role of Chief Executive Officer of Pala, succeeding Jan Castro who has resigned from the role, with immediate effect.

Over the last 8 years, Mr. Castro’s leadership has produced a strong track-record of successful investments and value-creation at investee companies across the mining and mining-related sectors. Mr. Barton has been with Pala since its formation and moves to Chief Executive Officer from the role of Chief Investment Officer.

Commenting on the changes, Mr. Barton said, “On behalf of Pala I’d like to thank Jan for his vision, values and focus, which have been instrumental in making Pala what it is today. On a personal level I’d like to thank him for the guidance and mentoring over the years we’ve worked together, which allow me to now assume the role of CEO. Pala has an ... Read more »